Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Care seeking and treatment for hepatitis C infection in Rwanda: A qualitative study of patient experiences.
Van Nuil JI, Shumbusho F, Kateera F, Mukuralinda A, Kabahizi J, Muvunyi CM, Musabeyezu E, Mukabatsinda C, Mbituyumuremi A, Nsanzimana S, Mukerjee J, Gupta N. Van Nuil JI, et al. Among authors: musabeyezu e. Glob Public Health. 2020 Dec;15(12):1778-1788. doi: 10.1080/17441692.2020.1801787. Epub 2020 Jul 31. Glob Public Health. 2020. PMID: 32735478 Free article. Clinical Trial.
Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir-sofosbuvir (SHARED): a single-arm trial.
Gupta N, Mbituyumuremyi A, Kabahizi J, Ntaganda F, Muvunyi CM, Shumbusho F, Musabeyezu E, Mukabatsinda C, Ntirenganya C, Van Nuil JI, Kateera F, Camus G, Damascene MJ, Nsanzimana S, Mukherjee J, Grant PM. Gupta N, et al. Among authors: musabeyezu e. Lancet Gastroenterol Hepatol. 2019 Feb;4(2):119-126. doi: 10.1016/S2468-1253(18)30382-0. Epub 2018 Dec 11. Lancet Gastroenterol Hepatol. 2019. PMID: 30552056
Safety and Efficacy of Limited Laboratory Monitoring for Hepatitis C Treatment: A Blinded Clinical Trial in Rwanda.
Grant P, Shumbusho F, Van Nuil JI, Kateera F, Mukherjee J, Kabahizi J, Ntaganda F, Nsanzimana S, Mbituyumuremyi A, Damascene MJ, Muvunyi CM, Mukabatsinda C, Musabeyezu E, Ntirenganya C, Gupta N. Grant P, et al. Among authors: musabeyezu e. Hepatol Commun. 2020 Feb 4;4(4):569-576. doi: 10.1002/hep4.1482. eCollection 2020 Apr. Hepatol Commun. 2020. PMID: 32258951 Free PMC article.
Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators.
Serumondo J, Penkunas MJ, Niyikora J, Ngwije A, Kiromera A, Musabeyezu E, Umutesi J, Umuraza S, Musengimana G, Nsanzimana S. Serumondo J, et al. Among authors: musabeyezu e. BMC Public Health. 2020 Jun 16;20(1):946. doi: 10.1186/s12889-020-09000-0. BMC Public Health. 2020. PMID: 32546216 Free PMC article.
Improved quality of life following direct-acting antiviral treatment for chronic hepatitis C infection in Rwanda: Results from a clinical trial in sub-Saharan Africa (the SHARED study).
Van Nuil JI, Umutesi G, Shumbusho F, Kateera F, Dushimimana JD, Muvunyi CM, Musabeyezu E, Mukabatsinda C, Ntirenganya C, Kabahizi J, Serumondo J, Makuza JD, Nsanzimana S, Grant P, Gupta N. Van Nuil JI, et al. Among authors: musabeyezu e. J Viral Hepat. 2021 Jan;28(1):112-120. doi: 10.1111/jvh.13386. Epub 2020 Oct 4. J Viral Hepat. 2021. PMID: 32858774
Safety and efficacy of sofosbuvir-velpatasvir-voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial.
Gupta N, Manirambona L, Shumbusho F, Kabihizi J, Murangwa A, Serumondo J, Makuza JD, Nsanzimana S, Muvunyi CM, Mukabatsinda C, Musabeyezu E, Camus G, Grant PM, Kateera F. Gupta N, et al. Among authors: musabeyezu e. Lancet Gastroenterol Hepatol. 2022 Jun;7(6):542-551. doi: 10.1016/S2468-1253(21)00399-X. Epub 2022 Mar 3. Lancet Gastroenterol Hepatol. 2022. PMID: 35248212 Clinical Trial.
16 results